The only reason they'd even be mentioning the 50US for development costs is to back up that they're continuing to build out the project. Given that they would own the assets the only relevance is the '10% gross revenue royalty' - it would provide substance that some revenue might actually exist. Problem is that if they then sit on Phase2 for 10 years you're looking at 10% of the small Phase1 project, which isn't material.
- Forums
- ASX - By Stock
- GLN
- Ann: Galan Response to AFR Street Talk Article
Ann: Galan Response to AFR Street Talk Article, page-18
-
-
- There are more pages in this discussion • 204 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GLN (ASX) to my watchlist
|
|||||
Last
11.8¢ |
Change
-0.003(2.08%) |
Mkt cap ! $58.00M |
Open | High | Low | Value | Volume |
12.5¢ | 12.5¢ | 11.5¢ | $170.7K | 1.408M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
26 | 1037274 | 11.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.0¢ | 212382 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
26 | 1037274 | 0.115 |
18 | 953635 | 0.110 |
16 | 804456 | 0.105 |
22 | 1092781 | 0.100 |
2 | 70000 | 0.099 |
Price($) | Vol. | No. |
---|---|---|
0.120 | 183476 | 13 |
0.125 | 463357 | 28 |
0.130 | 465508 | 12 |
0.135 | 290500 | 7 |
0.140 | 331000 | 4 |
Last trade - 14.03pm 13/08/2024 (20 minute delay) ? |
Featured News
GLN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online